Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.
Fabrizio
F
F
Luzzatto
G
G
Ramon
R
R
Randi
M L
ML
De Silvestro
G
G
Girolami
A
A
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008655:Mesterolone / Q000627:therapeutic use; D010956:Plasmapheresis; D010976:Platelet Count; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000628:therapy*; D012685:Sepharose / Q000031:analogs & derivatives*; D013156:Splenectomy; D014750:Vincristine / Q000627:therapeutic use; D013205:Staphylococcal Protein A
D000305:Adrenal Cortex Hormones; D003613:Danazol; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D008655:Mesterolone; D011241:Prednisone; D012685:Sepharose; D014750:Vincristine; C042030:Staphylococcal protein A-sepharose; D013205:Staphylococcal Protein A